Efficacy of Analytical Technologies in Metabolomics Studies of the Gastrointestinal Cancers

References

• Ferlay, J.; Colombet, M.; Soerjomataram, I.; Mathers, C.; Parkin, D. M.; Piñeros, M.; Znaor, A.; Bray, F. Estimating the Global Cancer Incidence and Mortality in 2018: GLOBOCAN Sources and Methods. Int. J. Cancer 2019, 144, 1941–1953. DOI: 10.1002/ijc.31937.
   PubMed Web of Science ®Google Scholar
• WHO. Cancer Statistics. https://www.who.int/cancer/PRGlobocanFinal.pdf (accessed Jan 2, 2021).
   Google Scholar
• Bray, F. The Evolving Scale and Profile of Cancer Worldwide: Much Ado about Everything. Cancer Epidemiol. Biomarkers Prev. 2016, 25, 3–5. DOI: 10.1158/1055-9965.EPI-15-1109.
   PubMed Web of Science ®Google Scholar
• Arnold, M.; Abnet, C. C.; Neale, R. E.; Vignat, J.; Giovannucci, E. L.; McGlynn, K. A.; Bray, F. Global Burden of 5 Major Types of Gastrointestinal Cancer. Gastroenterology 2020, 159, 335–349.e15. DOI: 10.1053/j.gastro.2020.02.068.
   PubMed Web of Science ®Google Scholar
• Casamayor, M.; Morlock, R.; Maeda, H.; Ajani, J. Targeted Literature Review of the Global Burden of Gastric Cancer. Ecancermedicalscience 2018, 12, 883. DOI: 10.3332/ecancer.2018.883.
   PubMed Web of Science ®Google Scholar
• Akyüz, C.; Abuoglu, H.; Gunay, E.; Uzunoğlu, H.; Tilki, M.; Okuyan, G. Ç. Importance of Early Diagnosis of Gastrointestinal Stromal Tumors of the Stomach: Our 5-Year, Single-Center Experience. Int. Surg. 2018, 102, 440–445. DOI: 10.9738/INTSURG-D-17-00076.1.
   Web of Science ®Google Scholar
• Kim, J.-H.; Kim, S. S.; Lee, J. H.; Jung, D. H.; Cheung, D. Y.; Chung, W.-C.; Park, S.-H. Early Detection is Important to Reduce the Economic Burden of Gastric Cancer. J. Gastric Cancer 2018, 18, 82–89. DOI: 10.5230/jgc.2018.18.e7.
   PubMed Web of Science ®Google Scholar
• Kusumoto, H.; Tashiro, K.; Shimaoka, S.; Tsukasa, K.; Baba, Y.; Furukawa, S.; Furukawa, J.; Niihara, T.; Hirotsu, T.; Uozumi, T. Efficiency of Gastrointestinal Cancer Detection by Nematode-NOSE (N-NOSE). In Vivo 2020, 34, 73–80. DOI: 10.21873/invivo.11747.
   PubMed Web of Science ®Google Scholar
• Wishart, D. S. Metabolomics for Investigating Physiological and Pathophysiological Processes. Physiol. Rev. 2019, 99, 1819–1875. DOI: 10.1152/physrev.00035.2018.
   PubMed Web of Science ®Google Scholar
• Srivastava, A.; Creek, D. J. Discovery and Validation of Clinical Biomarkers of Cancer: A Review Combining Metabolomics and Proteomics. Proteomics 2019, 19, 1700448. DOI: 10.1002/pmic.201700448.
   Web of Science ®Google Scholar
• Armitage, E. G.; Southam, A. D. Monitoring Cancer Prognosis, Diagnosis and Treatment Efficacy Using Metabolomics and Lipidomics. Metabolomics 2016, 12, 146. DOI: 10.1007/s11306-016-1093-7.
   PubMed Web of Science ®Google Scholar
• Simińska, E.; Koba, M. Amino Acid Profiling as a Method of Discovering Biomarkers for Early Diagnosis of Cancer. Amino Acids 2016, 48, 1339–1345. DOI: 10.1007/s00726-016-2215-2.
   PubMed Web of Science ®Google Scholar
• Wang, J.; Zhang, T.; Shen, X.; Liu, J.; Zhao, D.; Sun, Y.; Wang, L.; Liu, Y.; Gong, X.; Liu, Y.; et al. Serum Metabolomics for Early Diagnosis of Esophageal Squamous Cell Carcinoma by UHPLC-QTOF/MS. Metabolomics 2016, 12, 116. DOI: 10.1007/s11306-016-1050-5.
   Web of Science ®Google Scholar
• Ma, Y.; Zhang, P.; Yang, Y.; Wang, F.; Qin, H. Metabolomics in the Fields of Oncology: A Review of Recent Research. Mol. Biol. Rep. 2012, 39, 7505–7511. DOI: 10.1007/s11033-012-1584-1.
   PubMed Web of Science ®Google Scholar
• Jacob, M.; Lopata, A. L.; Dasouki, M.; Abdel Rahman, A. M. Metabolomics toward Personalized Medicine. Mass Spectrom. Rev. 2019, 38, 221–238. DOI: 10.1002/mas.21548.
   PubMed Web of Science ®Google Scholar
• Schmidt, J. A.; Fensom, G. K.; Rinaldi, S.; Scalbert, A.; Appleby, P. N.; Achaintre, D.; Gicquiau, A.; Gunter, M. J.; Ferrari, P.; Kaaks, R.; et al. Patterns in Metabolite Profile Are Associated with Risk of More Aggressive Prostate Cancer: A Prospective Study of 3,057 Matched Case-Control Sets from EPIC. Int. J. Cancer 2020, 146, 720–730. DOI: 10.1002/ijc.32314.
   PubMed Web of Science ®Google Scholar
• Kouskoumvekaki, I.; Panagiotou, G. Navigating the Human Metabolome for Biomarker Identification and Design of Pharmaceutical Molecules. J. Biomed. Biotechnol. 2011, 2011, 1–19. DOI: 10.1155/2011/525497.
   Google Scholar
• Aebersold, R.; Agar, J. N.; Amster, I. J.; Baker, M. S.; Bertozzi, C. R.; Boja, E. S.; Costello, C. E.; Cravatt, B. F.; Fenselau, C.; Garcia, B. A.; et al. How Many Human Proteoforms Are There? Nat. Chem. Biol. 2018, 14, 206–214. DOI: 10.1038/nchembio.2576.
   PubMed Web of Science ®Google Scholar
• Ponomarenko, E. A.; Poverennaya, E. V.; Ilgisonis, E. V.; Pyatnitskiy, M. A.; Kopylov, A. T.; Zgoda, V. G.; Lisitsa, A. V.; Archakov, A. I. The Size of the Human Proteome: The Width and Depth. Int. J. Anal. Chem. 2016, 2016, 7436849. DOI: 10.1155/2016/7436849.
   PubMed Web of Science ®Google Scholar
• Imanishi, T. Protein-Coding and Noncoding RNA Genes. In Evolution of the Human Genome I. Evolutionary Studies, Saitou, N., Ed.; Springer: Tokyo, 2017; pp 93–116. DOI: 10.1007/978-4-431-56603-8_4.
   Google Scholar
• Yu, L.; Li, K.; Zhang, X. Next-Generation Metabolomics in Lung Cancer Diagnosis, Treatment and Precision Medicine: Mini Review. Oncotarget 2017, 8, 115774–115786. DOI: 10.18632/oncotarget.22404.
   PubMedGoogle Scholar
• Wishart, D. S. Emerging Applications of Metabolomics in Drug Discovery and Precision Medicine. Nat. Rev. Drug Discov. 2016, 15, 473–484. DOI: 10.1038/nrd.2016.32.
   PubMed Web of Science ®Google Scholar
• Bedard, P. L.; Hansen, A. R.; Ratain, M. J.; Siu, L. L. Tumour Heterogeneity in the Clinic. Nature 2013, 501, 355–364. DOI: 10.1038/nature12627.
   PubMed Web of Science ®Google Scholar
• Lamichhane, S.; Sen, P.; Dickens, A. M.; Hyötyläinen, T.; Orešič, M. An Overview of Metabolomics Data Analysis: Current Tools and Future Perspectives. Compr. Anal. Chem. 2018, 82, 387–413. DOI: 10.1016/bs.coac.2018.07.001.
   Google Scholar
• Schiffman, C.; Petrick, L.; Perttula, K.; Yano, Y.; Carlsson, H.; Whitehead, T.; Metayer, C.; Hayes, J.; Rappaport, S.; Dudoit, S. Filtering Procedures for Untargeted Lc-Ms Metabolomics Data. BMC Bioinf. 2019, 20, DOI: 10.1186/s12859-019-2871-9.
   Web of Science ®Google Scholar
• Saccenti, E.; Hoefsloot, H. C. J.; Smilde, A. K.; Westerhuis, J. A.; Hendriks, M. M. W. B. Reflections on Univariate and Multivariate Analysis of Metabolomics Data. Metabolomics 2014, 10, 361–374. DOI: 10.1007/s11306-013-0598-6.
   Web of Science ®Google Scholar
• Hyötyläinen, T.; Orešič, M. Systems Biology Strategies to Study Lipidomes in Health and Disease. Prog. Lipid Res. 2014, 55, 43–60. DOI: 10.1016/j.plipres.2014.06.001.
   PubMed Web of Science ®Google Scholar
• Kherif, F.; Latypova, A. Principal Component Analysis. In Machine Learning: Methods and Application to Brain Disorders; Mechelli, A., Vieira, S., Eds.; 2019; pp 209–225. DOI: 10.1016/B978-0-12-815739-8.00012-2.
   Google Scholar
• Westerhuis, J. A.; Hoefsloot, H. C. J.; Smit, S.; Vis, D. J.; Smilde, A. K.; Velzen, E. J. J.; Duijnhoven, J. P. M.; Dorsten, F. A. Assessment of PLSDA Cross Validation. Metabolomics 2008, 4, 81–89. DOI: 10.1007/s11306-007-0099-6.
   Web of Science ®Google Scholar
• Orešič, M.; Posti, J. P.; Kamstrup-Nielsen, M. H.; Takala, R. S. K.; Lingsma, H. F.; Mattila, I.; Jäntti, S.; Katila, A. J.; Carpenter, K. L. H.; Ala-Seppälä, H.; et al. Human Serum Metabolites Associate with Severity and Patient Outcomes in Traumatic Brain Injury. EBioMedicine 2016, 12, 118–126. DOI: 10.1016/j.ebiom.2016.07.015.
   PubMed Web of Science ®Google Scholar
• De Noord, O. E.; Theobald, E. H. Multilevel Component Analysis and Multilevel PLS of Chemical Process Data. J. Chemometrics 2005, 19, 301–307. DOI: 10.1002/cem.933.
   Web of Science ®Google Scholar
• Kalivodová, A.; Hron, K.; Filzmoser, P.; Najdekr, L.; Janečková, H.; Adam, T. PLS-DA for Compositional Data with Application to Metabolomics. J. Chemometrics 2015, 29, 21–28. DOI: 10.1002/cem.2657.
   Web of Science ®Google Scholar
• Sjögren, M.; Li, H.; Banner, C.; Rafter, J.; Westerholm, R.; Rannug, U. Influence of Physical and Chemical Characteristics of Diesel Fuels and Exhaust Emissions on Biological Effects of Particle Extracts: A Multivariate Statistical Analysis of Ten Diesel Fuels. Chem. Res. Toxicol. 1996, 9, 197–207. DOI: 10.1021/tx950095w.
   PubMed Web of Science ®Google Scholar
• Worley, B.; Powers, R. PCA as a Practical Indicator of OPLS-DA Model Reliability. Curr. Metabolomics 2016, 4, 97–103. DOI: 10.2174/2213235x04666160613122429.
   PubMed Web of Science ®Google Scholar
• Westerhuis, J. A.; van Velzen, E. J. J.; Hoefsloot, H. C. J.; Smilde, A. K. Multivariate Paired Data Analysis: Multilevel PLSDA versus OPLSDA. Metabolomics 2010, 6, 119–128. DOI: 10.1007/s11306-009-0185-z.
   PubMed Web of Science ®Google Scholar
• Barsouk, A.; Rawla, P. Epidemiology of Gastric Cancer: Global Trends, Risk Factors and Prevention. Prz. Gastroenterol. 2019, 14, 26–38. DOI: 10.5114/pg.2018.80001.
   PubMed Web of Science ®Google Scholar
• Thrift, A. P.; El-Serag, H. B. Burden of Gastric Cancer. Clin. Gastroenterol. Hepatol. 2020, 18, 534–542. DOI: 10.1016/j.cgh.2019.07.045.
   PubMed Web of Science ®Google Scholar
• Sitarz, R.; Skierucha, M.; Mielko, J.; Offerhaus, G. J. A.; Maciejewski, R.; Polkowski, W. P. Gastric Cancer: Epidemiology, Prevention, Classification, and Treatment. Cancer Manag. Res. 2018, 10, 239–248. DOI: 10.2147/CMAR.S149619.
   PubMed Web of Science ®Google Scholar
• Necula, L.; Matei, L.; Dragu, D.; Neagu, A. I.; Mambet, C.; Nedeianu, S.; Bleotu, C.; Diaconu, C. C.; Chivu-Economescu, M. Recent Advances in Gastric Cancer Early Diagnosis. World J. Gastroenterol. 2019, 25, 2029–2044. DOI: 10.3748/wjg.v25.i17.2029.
   PubMed Web of Science ®Google Scholar
• Choi, J. M.; Park, W. S.; Song, K. Y.; Lee, H. J.; Jung, B. H. Development of Simultaneous Analysis of Tryptophan Metabolites in Serum and Gastric Juice - An Investigation Towards Establishing a Biomarker Test for Gastric Cancer Diagnosis. Biomed. Chromatogr. 2016, 30, 1963–1974. DOI: 10.1002/bmc.3773.
   PubMed Web of Science ®Google Scholar
• Miyagi, Y.; Higashiyama, M.; Gochi, A.; Akaike, M.; Ishikawa, T.; Miura, T.; Saruki, N.; Bando, E.; Kimura, H.; Imamura, F.; et al. Plasma Free Amino Acid Profiling of Five Types of Cancer Patients and Its Application for Early Detection. PLoS ONE 2011, 6, e24143. DOI: 10.1371/journal.pone.0024143.
   PubMed Web of Science ®Google Scholar
• Lario, S.; Ramírez-Lázaro, M. J.; Sanjuan-Herráez, D.; Brunet-Vega, A.; Pericay, C.; Gombau, L.; Junquera, F.; Quintás, G.; Calvet, X. Plasma Sample Based Analysis of Gastric Cancer Progression Using Targeted Metabolomics. Sci. Rep. 2017, 7, 17774. DOI: 10.1038/s41598-017-17921-x.
   PubMed Web of Science ®Google Scholar
• Kuligowski, J.; Sanjuan-Herráez, D.; Vázquez-Sánchez, M. A.; Brunet-Vega, A.; Pericay, C.; Ramírez-Lázaro, M. J.; Lario, S.; Gombau, L.; Junquera, F.; Calvet, X.; Quintás, G. Metabolomic Analysis of Gastric Cancer Progression within the Correa’s Cascade Using Ultraperformance Liquid Chromatography–Mass Spectrometry. J. Proteome Res. 2016, 15, 2729–2738. DOI: 10.1021/acs.jproteome.6b00281.
   PubMed Web of Science ®Google Scholar
• Yu, L.; Aa, J.; Xu, J.; Sun, M.; Qian, S.; Cheng, L.; Yang, S.; Shi, R. Metabolomic Phenotype of Gastric Cancer and Precancerous Stages Based on Gas Chromatography Time-of-Flight Mass Spectrometry. J. Gastroenterol. Hepatol. 2011, 26, 1290–1297. DOI: 10.1111/j.1440-1746.2011.06724.x.
   PubMed Web of Science ®Google Scholar
• Song, H.; Peng, J.-S.; Dong-Sheng, Y.; Yang, Z.-L.; Liu, H.-L.; Zeng, Y.-K.; Shi, X.-P.; Lu, B.-Y. Serum Metabolic Profiling of Human Gastric Cancer Based on Gas Chromatography/Mass Spectrometry. Braz. J. Med. Biol. Res. 2012, 45, 78–85. DOI: 10.1590/S0100-879X2011007500158.
   PubMed Web of Science ®Google Scholar
• Ikeda, A.; Nishiumi, S.; Shinohara, M.; Yoshie, T.; Hatano, N.; Okuno, T.; Bamba, T.; Fukusaki, E.; Takenawa, T.; Azuma, T.; Yoshida, M. Serum Metabolomics as a Novel Diagnostic Approach for Gastrointestinal Cancer. Biomed. Chromatogr. 2012, 26, 548–558. DOI: 10.1002/bmc.1671.
   PubMed Web of Science ®Google Scholar
• Wu, H.; Xue, R.; Tang, Z.; Deng, C.; Liu, T.; Zeng, H.; Sun, Y.; Shen, X. Metabolomic Investigation of Gastric Cancer Tissue Using Gas Chromatography/Mass Spectrometry. Anal. Bioanal. Chem. 2010, 396, 1385–1395. DOI: 10.1007/s00216-009-3317-4.
   PubMed Web of Science ®Google Scholar
• Chen, Y.; Zhang, J.; Guo, L.; Liu, L.; Wen, J.; Xu, L.; Yan, M.; Li, Z.; Zhang, X.; Nan, P.; et al. A Characteristic Biosignature for Discrimination of Gastric Cancer from Healthy Population by High Throughput GC-MS Analysis. Oncotarget 2016, 7, 87496–87510. DOI: 10.18632/oncotarget.11754.
   PubMedGoogle Scholar
• Tong, H.; Wang, Y.; Li, Y.; Liu, S.; Chi, C.; Liu, D.; Guo, L.; Li, E.; Wang, C. Volatile Organic Metabolites Identify Patients with Gastric Carcinoma, Gastric Ulcer, or Gastritis and Control Patients. Cancer Cell Int. 2017, 17, 108. DOI: 10.1186/s12935-017-0475-x.
   PubMed Web of Science ®Google Scholar
• Wang, H.; Zhang, H.; Deng, P.; Liu, C.; Li, D.; Jie, H.; Zhang, H.; Zhou, Z.; Zhao, Y.-L. Tissue Metabolic Profiling of Human Gastric Cancer Assessed by 1 H NMR. BMC Cancer 2016, 16, 371. DOI: 10.1186/s12885-016-2356-4.
   PubMed Web of Science ®Google Scholar
• Chan, A. W.; Mercier, P.; Schiller, D.; Bailey, R.; Robbins, S.; Eurich, D. T.; Sawyer, M. B.; Broadhurst, D. 1H-NMR Urinary Metabolomic Profiling for Diagnosis of Gastric Cancer. Br. J. Cancer 2016, 114, 59–62. DOI: 10.1038/bjc.2015.414.
   PubMed Web of Science ®Google Scholar
• Gu, J.; Hu, X.; Shao, W.; Ji, T.; Yang, W.; Zhuo, H.; Jin, Z.; Huang, H.; Chen, J.; Huang, C.; Lin, D. Metabolomic Analysis Reveals Altered Metabolic Pathways in a Rat Model of Gastric Carcinogenesis. Oncotarget 2016, 7, 60053–60073. DOI: 10.18632/oncotarget.11049.
   PubMedGoogle Scholar
• Jung, J.; Jung, Y.; Bang, E. J.; Cho, S.-I.; Jang, Y.-J.; Kwak, J.-M.; Ryu, D. H.; Park, S.; Hwang, G.-S. Noninvasive Diagnosis and Evaluation of Curative Surgery for Gastric Cancer by Using NMR-Based Metabolomic Profiling. Ann. Surg. Oncol. 2014, 21, 736–742. DOI: 10.1245/s10434-014-3886-0.
   PubMed Web of Science ®Google Scholar
• Kaji, S.; Irino, T.; Kusuhara, M.; Makuuchi, R.; Yamakawa, Y.; Tokunaga, M.; Tanizawa, Y.; Bando, E.; Kawamura, T.; Kami, K.; et al. Metabolomic Profiling of Gastric Cancer Tissues Identified Potential Biomarkers for Predicting Peritoneal Recurrence. Gastric Cancer 2020, 23, 874–883. DOI: 10.1007/s10120-020-01065-5.
   PubMed Web of Science ®Google Scholar
• Chen, J. L.; Fan, J.; Lu, X. J. CE-MS Based on Moving Reaction Boundary Method for Urinary Metabolomic Analysis of Gastric Cancer Patients. Electrophoresis 2014, 35, 1032–1039. DOI: 10.1002/elps.201300243.
   PubMed Web of Science ®Google Scholar
• Erawijantari, P. P.; Mizutani, S.; Shiroma, H.; Shiba, S.; Nakajima, T.; Sakamoto, T.; Saito, Y.; Fukuda, S.; Yachida, S.; Yamada, T. Influence of Gastrectomy for Gastric Cancer Treatment on Faecal Microbiome and Metabolome Profiles. Gut 2020, 69, 1404–1415. DOI: 10.1136/gutjnl-2019-319188.
   PubMed Web of Science ®Google Scholar
• Deng, K.; Lin, S.; Zhou, L.; Li, Y.; Chen, M.; Wang, Y.; Li, Y. High Levels of Aromatic Amino Acids in Gastric Juice during the Early Stages of Gastric Cancer Progression. PLoS ONE 2012, 7, e49434. DOI: 10.1371/journal.pone.0049434.
   PubMed Web of Science ®Google Scholar
• Lai, H.-S.; Lee, J.-C.; Lee, P.-H.; Wang, S.-T.; Chen, W.-J. Plasma Free Amino Acid Profile in Cancer Patients. Semin. Cancer Biol. 2005, 15, 267–276. DOI: 10.1016/j.semcancer.2005.04.003.
   PubMed Web of Science ®Google Scholar
• Li, J.; Peng, Y.; Duan, Y. Diagnosis of Breast Cancer Based on Breath Analysis: An Emerging Method. Crit. Rev. Oncol. Hematol. 2013, 87, 28–40. DOI: 10.1016/j.critrevonc.2012.11.007.
   PubMed Web of Science ®Google Scholar
• Kischkel, S.; Miekisch, W.; Fuchs, P.; Schubert, J. K. Breath Analysis during One-Lung Ventilation in Cancer Patients. Eur. Respir. J. 2012, 40, 706–713. DOI: 10.1183/09031936.00125411.
   PubMedGoogle Scholar
• Ressom, H. W.; Xiao, J. F.; Tuli, L.; Varghese, R. S.; Zhou, B.; Tsai, T.-H.; Ranjbar, M. R. N.; Zhao, Y.; Wang, J.; Di Poto, C.; et al. Utilization of Metabolomics to Identify Serum Biomarkers for Hepatocellular Carcinoma in Patients with Liver Cirrhosis. Anal. Chim. Acta 2012, 743, 90–100. DOI: 10.1016/j.aca.2012.07.013.
   PubMed Web of Science ®Google Scholar
• Altomare, D. F.; Di Lena, M.; Porcelli, F.; Trizio, L.; Travaglio, E.; Tutino, M.; Dragonieri, S.; Memeo, V.; De Gennaro, G. Exhaled Volatile Organic Compounds Identify Patients with Colorectal Cancer. Br. J. Surg. 2013, 100, 144–150. DOI: 10.1002/bjs.8942.
   PubMed Web of Science ®Google Scholar
• Emwas, A.-H.; Roy, R.; McKay, R. T.; Tenori, L.; Saccenti, E.; Gowda, G. A. N.; Raftery, D.; Alahmari, F.; Jaremko, L.; Jaremko, M.; Wishart, D. S. NMR Spectroscopy for Metabolomics Research. Metabolites 2019, 9, 123. DOI: 10.3390/metabo9070123.
   PubMed Web of Science ®Google Scholar
• Krishnan, P.; Kruger, N. J.; Ratcliffe, R. G. Metabolite Fingerprinting and Profiling in Plants Using NMR. J. Exp. Bot. 2005, 56, 255–265. DOI: 10.1093/jxb/eri010.
   PubMed Web of Science ®Google Scholar
• Araghi, M.; Soerjomataram, I.; Jenkins, M.; Brierley, J.; Morris, E.; Bray, F.; Arnold, M. Global Trends in Colorectal Cancer Mortality: Projections to the Year 2035. Int. J. Cancer 2019, 144, 2992–3000. DOI: 10.1002/ijc.32055.
   PubMed Web of Science ®Google Scholar
• Chen, L.; Lu, D.; Sun, K.; Xu, Y.; Hu, P.; Li, X.; Xu, F. Identification of Biomarkers Associated with Diagnosis and Prognosis of Colorectal Cancer Patients Based on Integrated Bioinformatics Analysis. Gene 2019, 692, 119–125. DOI: 10.1016/j.gene.2019.01.001.
   PubMed Web of Science ®Google Scholar
• Siegel, R. L.; Miller, K. D.; Jemal, A. Cancer Statistics, 2015. CA: Cancer J. Clin. 2015, 65, 5–29. DOI: 10.3322/caac.21254.
   PubMed Web of Science ®Google Scholar
• Aftabi, Y.; Zarredar, H.; Sheikhi, M.; Khoshkam, Z.; Colagar, A. H. Induction of AHR Gene Expression in Colorectal Cancer Cell Lines by Cucurbitacins D, E, and I. J. Cell Mol. Res. 2019, 10, 67–75. DOI: 10.22067/jcmr.v10i2.74806.
   Google Scholar
• Kim, E. R.; Kwon, H. N.; Nam, H.; Kim, J. J.; Park, S.; Kim, Y. H. Urine-NMR Metabolomics for Screening of Advanced Colorectal Adenoma and Early Stage Colorectal Cancer. Sci. Rep. 2019, 9, 4786. DOI: 10.1038/s41598-019-41216-y.
   PubMed Web of Science ®Google Scholar
• Hashim, N. A. A.; Ab-Rahim, S.; Suddin, L. S.; Saman, M. S. A.; Mazlan, M. Global Serum Metabolomics Profiling of Colorectal Cancer. Mol. Clin. Oncol. 2019, 11, 3–14. DOI: 10.3892/mco.2019.1853.
   PubMed Web of Science ®Google Scholar
• Zhu, J.; Djukovic, D.; Deng, L.; Gu, H.; Himmati, F.; Chiorean, E. G.; Raftery, D. Colorectal Cancer Detection Using Targeted Serum Metabolic Profiling. J. Proteome Res. 2014, 13, 4120–4130. DOI: 10.1021/pr500494u.
   PubMed Web of Science ®Google Scholar
• Long, Y.; Sanchez-Espiridion, B.; Lin, M.; White, L.; Mishra, L.; Raju, G. S.; Kopetz, S.; Eng, C.; Hildebrandt, M. A. T.; Chang, D. W.; et al. Global and Targeted Serum Metabolic Profiling of Colorectal Cancer Progression. Cancer 2017, 123, 4066–4074. DOI: 10.1002/cncr.30829.
   PubMed Web of Science ®Google Scholar
• Tan, B.; Qiu, Y.; Zou, X.; Chen, T.; Xie, G.; Cheng, Y.; Dong, T.; Zhao, L.; Feng, B.; Hu, X.; et al. Metabonomics Identifies Serum Metabolite Markers of Colorectal Cancer. J. Proteome Res. 2013, 12, 3000–3009. DOI: 10.1021/pr400337b.
   PubMed Web of Science ®Google Scholar
• Brown, D. G.; Rao, S.; Weir, T. L.; O'Malia, J.; Bazan, M.; Brown, R. J.; Ryan, E. P. Metabolomics and Metabolic Pathway Networks from Human Colorectal Cancers, Adjacent Mucosa, and Stool. Cancer Metab. 2016, 4, 11. DOI: 10.1186/s40170-016-0151-y.
   PubMed Web of Science ®Google Scholar
• Farshidfar, F.; Kopciuk, K. A.; Hilsden, R.; Elizabeth McGregor, S.; Mazurak, V. C.; Donald Buie, W.; MacLean, A.; Vogel, H. J.; Bathe, O. F. A Quantitative Multimodal Metabolomic Assay for Colorectal Cancer. BMC Cancer 2018, 18, 26. DOI: 10.1186/s12885-017-3923-z.
   PubMed Web of Science ®Google Scholar
• Nishiumi, S.; Kobayashi, T.; Ikeda, A.; Yoshie, T.; Kibi, M.; Izumi, Y.; Okuno, T.; Hayashi, N.; Kawano, S.; Takenawa, T.; et al. A Novel Serum Metabolomics-Based Diagnostic Approach for Colorectal Cancer. PLoS ONE 2012, 7, e40459. DOI: 10.1371/journal.pone.0040459.
   PubMed Web of Science ®Google Scholar
• Farshidfar, F.; Weljie, A. M.; Kopciuk, K. A.; Hilsden, R.; McGregor, S. E.; Buie, W. D.; MacLean, A.; Vogel, H. J.; Bathe, O. F. A Validated Metabolomic Signature for Colorectal Cancer: Exploration of the Clinical Value of Metabolomics. Br. J. Cancer 2016, 115, 848–857. DOI: 10.1038/bjc.2016.243.
   PubMed Web of Science ®Google Scholar
• Deng, L.; Gu, H.; Zhu, J.; Nagana Gowda, G. A.; Djukovic, D.; Chiorean, E. G.; Raftery, D. Combining NMR and LC/MS Using Backward Variable Elimination: Metabolomics Analysis of Colorectal Cancer, Polyps, and Healthy Controls. Anal. Chem. 2016, 88, 7975–7983. DOI: 10.1021/acs.analchem.6b00885.
   PubMed Web of Science ®Google Scholar
• Wang, Z.; Lin, Y.; Liang, J.; Huang, Y.; Ma, C.; Liu, X.; Yang, J. NMR-Based Metabolomic Techniques Identify Potential Urinary Biomarkers for Early Colorectal Cancer Detection. Oncotarget 2017, 8, 105819–105831. DOI: 10.18632/oncotarget.22402.
   PubMedGoogle Scholar
• Vahabi, F.; Sadeghi, S.; Arjmand, M.; Mirkhani, F.; Hosseini, E.; Mehrabanfar, M.; Hajhosseini, R.; Iravani, A.; Bayat, P.; Zamani, Z. Staging of Colorectal Cancer Using Serum Metabolomics With1HNMR Spectroscopy. Iran. J. Basic Med. Sci. 2017, 20, 836–841. DOI: 10.22038/ijbms.2017.9022.
   Web of Science ®Google Scholar
• Udo, R.; Katsumata, K.; Kuwabara, H.; Enomoto, M.; Ishizaki, T.; Sunamura, M.; Nagakawa, Y.; Soya, R.; Sugimoto, M.; Tsuchida, A. Urinary Charged Metabolite Profiling of Colorectal Cancer Using Capillary Electrophoresis-Mass Spectrometry. Sci. Rep. 2020, 10, 1–10. DOI: 10.1038/s41598-020-78038-2.
   PubMed Web of Science ®Google Scholar
• Gao, P.; Zhou, C.; Zhao, L.; Zhang, G.; Zhang, Y. Tissue Amino Acid Profile Could Be Used to Differentiate Advanced Adenoma from Colorectal Cancer. J. Pharm. Biomed. Anal. 2016, 118, 349–355. DOI: 10.1016/j.jpba.2015.11.007.
   PubMed Web of Science ®Google Scholar
• Uchiyama, K.; Yagi, N.; Mizushima, K.; Higashimura, Y.; Hirai, Y.; Okayama, T.; Yoshida, N.; Katada, K.; Kamada, K.; Handa, O.; et al. Serum Metabolomics Analysis for Early Detection of Colorectal Cancer. J. Gastroenterol. 2017, 52, 677–694. DOI: 10.1007/s00535-016-1261-6.
   PubMed Web of Science ®Google Scholar
• Miller, K. D.; Siegel, R. L.; Lin, C. C.; Mariotto, A. B.; Kramer, J. L.; Rowland, J. H.; Stein, K. D.; Alteri, R.; Jemal, A. Cancer Treatment and Survivorship Statistics, 2016. CA: Cancer J. Clin. 2016, 66, 271–289. DOI: 10.3322/caac.21349.
   PubMed Web of Science ®Google Scholar
• Liu, K.; Zhao, T.; Wang, J.; Chen, Y.; Zhang, R.; Lan, X.; Que, J. Etiology, Cancer Stem Cells and Potential Diagnostic Biomarkers for Esophageal Cancer. Cancer Lett. 2019, 458, 21–28. DOI: 10.1016/j.canlet.2019.05.018.
   PubMed Web of Science ®Google Scholar
• Zhu, Z. J.; Qi, Z.; Zhang, J.; Xue, W. H.; Li, L. F.; Shen, Z. B.; Li, Z. Y.; Yuan, Y. L.; Wang, W.; Bin; Zhao, J. Untargeted Metabolomics Analysis of Esophageal Squamous Cell Carcinoma Discovers Dysregulated Metabolic Pathways and Potential Diagnostic Biomarkers. J. Cancer 2020, 11, 3944–3954. DOI: 10.7150/jca.41733.
   PubMed Web of Science ®Google Scholar
• Nishiumi, S.; Fujigaki, S.; Kobayashi, T.; Kojima, T.; Ito, Y.; Daiko, H.; Kato, K.; Shoji, H.; Kodama, Y.; Honda, K.; et al. Metabolomics-Based Discovery of Serum Biomarkers to Predict the Side-Effects of Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma. Anticancer Res. 2019, 39, 519–526. DOI: 10.21873/anticanres.13143.
   PubMed Web of Science ®Google Scholar
• Ma, H.; Hasim, A.; Mamtimin, B.; Kong, B.; Zhang, H.-P.; Sheyhidin, I. Plasma Free Amino Acid Profiling of Esophageal Cancer Using High-Performance Liquid Chromatography Spectroscopy. World J. Gastroenterol. 2014, 20, 8653–8659. DOI: 10.3748/wjg.v20.i26.8653.
   PubMed Web of Science ®Google Scholar
• Xu, J.; Chen, Y.; Zhang, R.; He, J.; Song, Y.; Wang, J.; Wang, H.; Wang, L.; Zhan, Q.; Abliz, Z. Global Metabolomics Reveals Potential Urinary Biomarkers of Esophageal Squamous Cell Carcinoma for Diagnosis and Staging. Sci. Rep. 2016, 6, 1–10.
   PubMed Web of Science ®Google Scholar
• Xu, J.; Chen, Y.; Zhang, R.; Song, Y.; Cao, J.; Bi, N.; Wang, J.; He, J.; Bai, J.; Dong, L.; et al. Global and Targeted Metabolomics of Esophageal Squamous Cell Carcinoma Discovers Potential Diagnostic and Therapeutic Biomarkers. Mol. Cell. Proteomics 2013, 12, 1306–1318. DOI: 10.1074/mcp.M112.022830.
   PubMed Web of Science ®Google Scholar
• Zhang, H.; Wang, L.; Hou, Z.; Ma, H.; Mamtimin, B.; Hasim, A.; Sheyhidin, I. Metabolomic Profiling Reveals Potential Biomarkers in Esophageal Cancer Progression Using Liquid Chromatography-Mass Spectrometry Platform. Biochem. Biophys. Res. Commun. 2017, 491, 119–125. DOI: 10.1016/j.bbrc.2017.07.060.
   PubMed Web of Science ®Google Scholar
• Sanchez-Espiridion, B.; Liang, D.; Ajani, J. A.; Liang, S.; Ye, Y.; Hildebrandt, M. A. T.; Gu, J.; Wu, X. Identification of Serum Markers of Esophageal Adenocarcinoma by Global and Targeted Metabolic Profiling. Clin. Gastroenterol. Hepatol. 2015, 13, 1730–1737. DOI: 10.1016/j.cgh.2015.05.023.
   PubMed Web of Science ®Google Scholar
• Liu, R.; Peng, Y.; Li, X.; Wang, Y.; Pan, E.; Guo, W.; Pu, Y.; Yin, L. Identification of Plasma Metabolomic Profiling for Diagnosis of Esophageal Squamous-Cell Carcinoma Using an UPLC/TOF/MS Platform. Int. J. Mol. Sci. 2013, 14, 8899–8911. DOI: 10.3390/ijms14058899.
   PubMed Web of Science ®Google Scholar
• Jin, H.; Qiao, F.; Chen, L.; Lu, C.; Xu, L.; Gao, X. Serum Metabolomic Signatures of Lymph Node Metastasis of Esophageal Squamous Cell Carcinoma. J. Proteome Res. 2014, 13, 4091–4103. DOI: 10.1021/pr500483z.
   PubMed Web of Science ®Google Scholar
• Zhu, X.; Wang, K.; Liu, G.; Wang, Y.; Xu, J.; Liu, L.; Li, M.; Shi, J.; Aa, J.; Yu, L. Metabolic Perturbation and Potential Markers in Patients with Esophageal Cancer. Gastroenterol. Res. Pract. 2017, 2017, 5469597. DOI: 10.1155/2017/5469597.
   PubMed Web of Science ®Google Scholar
• Zhang, X.; Xu, L.; Shen, J.; Cao, B.; Cheng, T.; Zhao, T.; Liu, X.; Zhang, H. Metabolic Signatures of Esophageal Cancer: NMR-Based Metabolomics and UHPLC-Based Focused Metabolomics of Blood Serum. Biochim. Biophys. Acta - Mol. Basis Dis. 2013, 1832, 1207–1216. DOI: 10.1016/j.bbadis.2013.03.009.
   PubMed Web of Science ®Google Scholar
• Wang, L.; Chen, J.; Chen, L.; Deng, P.; Bu, Q.; Xiang, P.; Li, M.; Lu, W.; Xu, Y.; Lin, H.; et al. 1H-NMR Based Metabonomic Profiling of Human Esophageal Cancer Tissue. Mol. Cancer 2013, 12, 25. DOI: 10.1186/1476-4598-12-25.
   PubMed Web of Science ®Google Scholar
• Reed, M. A. C.; Singhal, R.; Ludwig, C.; Carrigan, J. B.; Ward, D. G.; Taniere, P.; Alderson, D.; Günther, U. L. Metabolomic Evidence for a Field Effect in Histologically Normal and Metaplastic Tissues in Patients with Esophageal Adenocarcinoma. Neoplasia 2017, 19, 165–174. DOI: 10.1016/j.neo.2016.11.003.
   PubMed Web of Science ®Google Scholar
• Yang, Z.; Liu, Y.; Ma, L.; Wen, X.; Ji, H.; Li, K. Exploring Potential Biomarkers of Early Stage Esophageal Squamous Cell Carcinoma in Pre-and Post-Operative Serum Metabolomic Fingerprint Spectrum Using 1H-NMR Method. Am. J. Transl. Res. 2019, 11, 819–831.
   PubMed Web of Science ®Google Scholar
• Tokunaga, M.; Kami, K.; Ozawa, S.; Oguma, J.; Kazuno, A.; Miyachi, H.; Ohashi, Y.; Kusuhara, M.; Terashima, M. Metabolome Analysis of Esophageal Cancer Tissues Using Capillary Electrophoresis-Time-of-Flight Mass Spectrometry. Int. J. Oncol. 2018, 52, 1947–1958. DOI: 10.3892/ijo.2018.4340.
   PubMed Web of Science ®Google Scholar
• Huang, S.; Guo, Y.; Li, Z.; Zhang, Y.; Zhou, T.; You, W.; Pan, K.; Li, W. A Systematic Review of Metabolomic Profiling of Gastric Cancer and Esophageal Cancer. Cancer Biol. Med. 2020, 17, 181–198. DOI: 10.20892/j.issn.2095-3941.2019.0348.
   PubMed Web of Science ®Google Scholar